• Products
  • Insights
  • Practice Management
  • Resources
  • About Us

Robert L. Deresiewicz

Senior Managing Director at Wellington Management, Global Industry Analyst



Robert L. Deresiewicz, Senior Managing Director and Global Industry Analyst, is involved in portfolio management and securities analysis for the Hartford Healthcare Fund. Bob is a biotechnology analyst and member of Wellington’s health care team within Global Industry Research. He conducts fundamental research on companies within his coverage, and makes Buy/Sell recommendations to portfolio managers based on his findings and market conditions. He also participates in the management of several health care and biotechnology sector portfolios.

Prior to joining Wellington Management in 2000, Bob was an assistant professor of medicine at the Harvard Medical School, and an associate physician in the Division of Infectious Diseases at the Brigham and Women’s Hospital, where he treated patients, taught medical students, and conducted biomedical research (1990 – 1998). He trained in infectious disease at the Harvard Medical School (1987 – 1990), in tropical medicine at the Hadassah Medical School in Jerusalem (1986 – 1987), and in internal medicine at the Columbia-Presbyterian Medical Center in New York (1983 – 1986). 

Bob received his MBA from the Harvard Business School (2000), his MD from the Mount Sinai School of Medicine (1983), and his BA in biochemistry summa cum laude from Columbia University (1979). He is Board Certified in Internal Medicine and Infectious Diseases and was an elected fellow of the American College of Physicians and of the Infectious Disease Society of America.


Professional experience since 1983

Wellington Management

Brigham and Women’s Hospital

Harvard Medical School

Hadassah Medical School

Columbia-Presbyterian Medical Center


BA, Columbia University
MD, Mount Sinai School of Medicine
MBA, Harvard Business School


The material on this site is for informational and educational purposes only. The material should not be considered tax or legal advice and is not to be relied on as a forecast. The material is also not a recommendation or advice regarding any particular security, strategy or product. Hartford Funds does not represent that any products or strategies discussed are appropriate for any particular investor so investors should seek their own professional advice before investing. Hartford Funds does not serve as a fiduciary. Content is current as of the publication date or date indicated, and may be superseded by subsequent market and economic conditions.

Investing involves risk, including the possible loss of principal. Investors should carefully consider a fund's investment objectives, risks, charges and expenses. This and other important information is contained in the mutual fund, or ETF summary prospectus and/or prospectus, which can be obtained from a financial professional and should be read carefully before investing.

Mutual funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA|SIPC. ETFs are distributed by ALPS Distributors, Inc. (ALPS). Advisory services may be provided by Hartford Funds Management Company, LLC (HFMC) or its wholly owned subsidiary, Lattice Strategies LLC (Lattice). Certain funds are sub-advised by Wellington Management Company LLP and/or Schroder Investment Management North America Inc (SIMNA). Schroder Investment Management North America Ltd. (SIMNA Ltd) serves as a secondary sub-adviser to certain funds. HFMC, Lattice, Wellington Management, SIMNA, and SIMNA Ltd. are all SEC registered investment advisers. Hartford Funds refers to HFD, Lattice, and HFMC, which are not affiliated with any sub-adviser or ALPS. The funds and other products referred to on this Site may be offered and sold only to persons in the United States and its territories.

© Copyright 2023 Hartford Funds Management Group, Inc. All Rights Reserved. Not FDIC Insured | No Bank Guarantee | May Lose Value